Emergent BioSolutions Inc. (EBS)
NYSE
Closed
Aug 25, 2026
Day's Range
5.2052 wk Range
4.36Overview - EBS - Emergent BioSolutions Inc.
Key Statistics
Valuation
Enterprise Value
737.68M
P/E (Trailing)
‪8.59‬
P/E (Forward)
‪5.38‬
PEG Ratio
‪0.0057‬
Price / Sales (TTM)
‪0.37‬
Price / Book
‪0.84‬
EV / EBITDA
‪3.17‬
Profitability
Gross Margin
‪57.18%‬
Profit Margin
‪-22.95%‬
Operating Margin
‪28.34%‬
Return on Assets
‪6.93%‬
Return on Equity
‪-40.29%‬
Ownership
Shares Outstanding
51.30M
Float
48.86M
Short % of Shares Outstanding
‪23.06%‬
Held by Insiders
‪4.25%‬
Held by Institutions
‪90.66%‬
Price stats
Beta
‪2.36‬
50-Day Avg
‪7.06‬
200-Day Avg
‪9.23‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - EBS - Emergent BioSolutions Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NYSE.
- EBSNYSEEmergent BioSolutions Inc.410.19MMarket Cap+15.09%52-week change8.59P/E (Trailing)‪-1.27%‬Profit Margin
- MRKNYSEMerck & Co., Inc.371.70BMarket Cap+44.69%52-week change122.04P/E (Trailing)‪4.76%‬Profit Margin
- PWRNYSEQuanta Services Inc.92.72BMarket Cap+36.40%52-week change72.98P/E (Trailing)‪4.03%‬Profit Margin
- CLNYSEColgate-Palmolive Company73.77BMarket Cap+8.43%52-week change35.86P/E (Trailing)‪9.68%‬Profit Margin
- DBNYSEDeutsche Bank AG72.19BMarket Cap+4.16%52-week change9.87P/E (Trailing)‪22.71%‬Profit Margin
- SENYSESea Ltd.70.85BMarket Cap-62.77%52-week change45.38P/E (Trailing)‪5.90%‬Profit Margin
- HLNNYSEHaleon Plc - ADR44.76BMarket Cap+5.40%52-week change20.32P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - EBS - Emergent BioSolutions Inc.
About
Emergent BioSolutions Inc. is a global life sciences company that primarily focuses on the development, manufacturing, and distribution of a wide array of medical products. These products are designed to address public health threats including chemical and biological agents, and infectious diseases. As an important…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
